GENEOS THERAPEUTICS

What this means for you

Registered since 04 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

87289084

Registration number

6119258

Mark type

Stylized text

Filed

04 Jan 2017

Published for opposition

07 Nov 2017

Registered

04 Aug 2020

Attorney of record

Muzamil Huq

Goods and services

• Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific research, namely, conducting clinical trials for others; Research and development of treatments for infectious diseases

Owner

• GENEOS THERAPEUTICS, INC., Philadelphia, PA, US
• GENEOS THERAPEUTICS, INC., Plymouth Meeting, PA, US
• Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
• Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US

Prosecution history

• 26 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 26 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 26 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 12 Aug 2025 — TEAS SECTION 8 & 15 RECEIVED
• 04 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 03 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 03 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 03 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 03 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 04 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
• 27 Jun 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 26 Jun 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 24 Jun 2020 — STATEMENT OF USE PROCESSING COMPLETE
• 05 Jun 2020 — USE AMENDMENT FILED
• 24 Jun 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL